Bicycle Therapeutics plc (50BA) — Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Bicycle Therapeutics plc (50BA) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow (€34.10 Million) in capital expenditures (€277.00K). See 50BA equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

€34.10 Million

EUR

Capital Expenditures

€277.00K

EUR

Data as of

Jun 2023

Most recent filing

Annual Capital Reinvestment Ratio for Bicycle Therapeutics plc (None–None)

Year-by-year Capital Reinvestment Ratio for Bicycle Therapeutics plc from None to None. For live market cap and broader valuation context, see Bicycle Therapeutics plc (50BA) total market value.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow